BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26792934)

  • 1. Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas.
    Lecoq AL; Bouligand J; Hage M; Cazabat L; Salenave S; Linglart A; Young J; Guiochon-Mantel A; Chanson P; Kamenický P
    Eur J Endocrinol; 2016 Apr; 174(4):523-30. PubMed ID: 26792934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study.
    Ferraù F; Romeo PD; Puglisi S; Ragonese M; Torre ML; Scaroni C; Occhi G; De Menis E; Arnaldi G; Trimarchi F; Cannavò S
    Endocrine; 2016 Dec; 54(3):762-767. PubMed ID: 26815903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
    Iacovazzo D; Caswell R; Bunce B; Jose S; Yuan B; Hernández-Ramírez LC; Kapur S; Caimari F; Evanson J; Ferraù F; Dang MN; Gabrovska P; Larkin SJ; Ansorge O; Rodd C; Vance ML; Ramírez-Renteria C; Mercado M; Goldstone AP; Buchfelder M; Burren CP; Gurlek A; Dutta P; Choong CS; Cheetham T; Trivellin G; Stratakis CA; Lopes MB; Grossman AB; Trouillas J; Lupski JR; Ellard S; Sampson JR; Roncaroli F; Korbonits M
    Acta Neuropathol Commun; 2016 Jun; 4(1):56. PubMed ID: 27245663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
    Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
    Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
    Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
    Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
    Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIP Mutations are not identified in patients with sporadic pituitary adenomas.
    DiGiovanni R; Serra S; Ezzat S; Asa SL
    Endocr Pathol; 2007; 18(2):76-8. PubMed ID: 17916996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
    Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
    Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial pituitary adenomas - who should be tested for AIP mutations?
    Korbonits M; Storr H; Kumar AV
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):351-6. PubMed ID: 22612670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mutations in sporadic pituitary adenomas--what to screen for?
    Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
    Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.